Heuser, Michael http://orcid.org/0000-0001-5318-9044
Smith, B. Douglas
Fiedler, Walter
Sekeres, Mikkael A.
Montesinos, Pau
Leber, Brian
Merchant, Akil
Papayannidis, Cristina
Pérez-Simón, José A.
Hoang, Caroline J.
O’Brien, Thomas
Ma, Weidong Wendy
Zeremski, Mirjana
O’Connell, Ashleigh
Chan, Geoffrey
Cortes, Jorge E.
Funding for this research was provided by:
Pfizer
Article History
Received: 10 February 2021
Accepted: 15 February 2021
First Online: 19 March 2021
Change Date: 12 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00277-021-04545-5
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki. The protocol was approved by institutional review boards at each study site.
: All patients provided written informed consent before study procedures began.
: This manuscript has been approved by all authors.
: Michael Heuser received research funding and honoraria from Pfizer, prIME Oncology, and Jazz Pharmaceuticals; served on advisory boards for AbbVie, Bayer Pharma AG, Daiichi Sankyo, Novartis, Pfizer, and Jazz Pharmaceuticals; and received research funding to his institute from Astellas, Bayer Pharma AG, BerGenBio, Daiichi Sankyo, Karyopharm, Novartis, Pfizer, and Roche. B. Douglas Smith served on an advisory board and was a consultant for Celgene, Jazz Pharmaceuticals, Novartis, and Pfizer. Walter Fiedler has participated in advisory boards for Amgen, Pfizer, Novartis, Jazz Pharmaceuticals, and ARIAD/Incyte; received research funding from Amgen; received support for meeting attendance from Amgen, Jazz Pharmaceuticals, Daiichi Sankyo Oncology, and Servier; and has received support for medical writing from Amgen, Pfizer, and AbbVie. Mikkael A. Sekeres is an advisory board member for Celgene. Pau Montesinos served on an advisory board for Celgene, Jazz Pharmaceuticals, Janssen, and Novartis; and has received research funding from Pfizer and Celgene. Brian Leber has received honoraria and served on advisory boards for Novartis, Pfizer, Celgene, AbbVie, Astellas, Jazz Pharmaceuticals, and Alexion; and was a consultant for Novartis and Pfizer. Akil Merchant is an advisory board member for Agios, Pfizer, and Takeda; and has received research funding from Pfizer. Cristina Papayannidis has received honoraria from Pfizer, Novartis, Incyte, and Amgen. José A. Pérez-Simón has received honoraria and or/research funding from Pfizer, Jazz Pharmaceuticals, Takeda, Amgen, Janssen, and Novartis. Caroline J. Hoang, Thomas O’Brien, Weidong Wendy Ma, Mirjana Zeremski, Ashleigh O’Connell, and Geoffrey Chan are all employees and shareholders of Pfizer. Jorge E. Cortes received research funding to his institution and consulting honoraria from Pfizer, Novartis, Astellas, Daiichi Sankyo, Jazz Pharmaceuticals, Takeda, and Celgene.